These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. High-dose allopurinol in patients with stable angina pectoris. Kim T; Kim J; Oh J; Kang SM; Lee MG Lancet; 2010 Oct; 376(9749):1298; author reply 1299-300. PubMed ID: 20951883 [No Abstract] [Full Text] [Related]
3. High-dose allopurinol in patients with stable angina pectoris. Liang Y; Wang S Lancet; 2010 Oct; 376(9749):1299; author reply 1299-300. PubMed ID: 20951887 [No Abstract] [Full Text] [Related]
4. Letter by Kielstein et al regarding article, "High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid". Kielstein JT; Woywodt A; Salpeter SR Circulation; 2007 May; 115(18):e450-1; author reply e451. PubMed ID: 17485587 [No Abstract] [Full Text] [Related]
5. [Effects of allopurinol on uric acid metabolism and lipid peroxidation in ischemic heart disease patients with stable angina]. Kaliakin IE; Mit'kin AF Kardiologiia; 1993; 33(2):15-7. PubMed ID: 8084119 [TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of renal dysfunction in patients with stable angina pectoris. Almquist T; Forslund L; Rehnqvist N; Hjemdahl P J Intern Med; 2006 Dec; 260(6):537-44. PubMed ID: 17116004 [TBL] [Abstract][Full Text] [Related]
7. Allopurinol a new anti-ischemic role for an old drug. Stone PH J Am Coll Cardiol; 2011 Aug; 58(8):829-30. PubMed ID: 21835318 [No Abstract] [Full Text] [Related]
8. Allopurinol for chronic stable angina: old drug, new tricks? Antony R; Dargie HJ Lancet; 2010 Jun; 375(9732):2126-7. PubMed ID: 20542555 [No Abstract] [Full Text] [Related]
9. Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial. Goicoechea M; Garcia de Vinuesa S; Verdalles U; Verde E; Macias N; Santos A; Pérez de Jose A; Cedeño S; Linares T; Luño J Am J Kidney Dis; 2015 Apr; 65(4):543-9. PubMed ID: 25595565 [TBL] [Abstract][Full Text] [Related]
10. Treatment of gout. Cohen MG Intern Med J; 2011 Jan; 41(1a):70-1. PubMed ID: 21265967 [No Abstract] [Full Text] [Related]
11. Effect of allopurinol on slowing allograft functional decline in kidney transplant recipients. Osadchuk L; Bashir MH; Tangirala B; Marcus RJ; Nashar K; Hussain SM; Sureshkumar KK Exp Clin Transplant; 2014 Jun; 12(3):190-4. PubMed ID: 24907717 [TBL] [Abstract][Full Text] [Related]
12. Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. Stamp LK; Taylor WJ; Jones PB; Dockerty JL; Drake J; Frampton C; Dalbeth N Arthritis Rheum; 2012 Aug; 64(8):2529-36. PubMed ID: 22488501 [TBL] [Abstract][Full Text] [Related]
13. [Treatment with allopurinol in gout and hyperuricemic renal disease]. Hood B; Olander R Lakartidningen; 1973 Mar; 70(13):1297-300. PubMed ID: 4699017 [No Abstract] [Full Text] [Related]
14. New angina drugs on the horizon? Harv Heart Lett; 2002 Feb; 12(6):5-6. PubMed ID: 11869968 [No Abstract] [Full Text] [Related]
15. [Allopurinol]. Scott JT Schweiz Med Wochenschr; 1967 Dec; 97(49):1659-62. PubMed ID: 5596893 [No Abstract] [Full Text] [Related]